Oxidized low-density lipoprotein is localized in the ventricles of hearts from patients with coronary heart disease

By Ekmekcioglu C.  

International Journal of Clinical & Laboratory Research, Vol. 30, Iss. 3, 2000-09 ,pp. : 133-140

Springer Publishing Company

Access to resources Recommend Favorite

Increased serum triglyceride clearance and elevated high-density lipoprotein 2 and 3 cholesterol during treatment of primary hypertriglyceridemia with bezafibrate

By Sakuma N.   Ikeuchi R.   Hibino T.   Yoshida T.   Mukai S.   Akita S.   Yajima K.   Miyabe H.   Goto T.   Takada N.   Ohte N.   Kunimatu M.   Kimura G.  

Current Therapeutic Research, Vol. 64, Iss. 9, 2003-11 ,pp. : 697-706

Elsevier

Access to resources Recommend Favorite

A retrospective meta-analysis of the efficacy and tolerability of fenofibrate 300 mg/d on high-density lipoprotein cholesterol levels in randomized, double-blind, comparative studies conducted in Japan

By Nakaya N.   Goto Y.  

Current Therapeutic Research, Vol. 64, Iss. 8, 2003-09 ,pp. : 634-644

Elsevier

Access to resources Recommend Favorite

Rehabilitation of elderly with coronary heart disease – Improvement in quality of life at a low cost

By Sandström Lena   Ståhle Agneta  

Advances in Physiotherapy, Vol. 7, Iss. 2, 2005-06 ,pp. : 60-66

Informa Healthcare

Access to resources Recommend Favorite

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

By Davidson M.H.   Palmisano J.   Wilson H.   Liss C.   Dicklin M.R.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2738-2753

Elsevier

Access to resources Recommend Favorite